Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Broggini

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|January 21, 1993
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studiesC Geroni, E Pesenti, G Tagliabue, et al.
British Journal of Cancer|August 1, 1991
Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancerG Balconi, Y Pang, M Broggini, et al.
Anticancer Research|February 24, 2001
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patientsM Broggini, G Buraggi, A Brenna, et al.
Cancer Research|March 1, 1997
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxelD Debernardis, E G Siré, P De Feudis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Molecular characterisation of a panel of human ovarian carcinoma xenograftsA M Codegoni, M I Nicoletti, G Buraggi, et al.
Bone|October 1, 1995
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosisS Adami, M Passeri, S Ortolani, et al.
Clinical and Experimental Rheumatology|May 1, 1993
Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesionsI Grazioli, M Avossa, A Bogliolo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitoninS Adami, M C Baroni, M Broggini, et al.
British Journal of Cancer|June 3, 2004
Antiangiogenic activity of aplidine, a new agent of marine originG Taraboletti, M Poli, R Dossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
DeltaNp63 expression is associated with poor survival in ovarian cancerS Marchini, M Marabese, E Marrazzo, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|January 21, 1993
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studiesC Geroni, E Pesenti, G Tagliabue, et al.
British Journal of Cancer|August 1, 1991
Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancerG Balconi, Y Pang, M Broggini, et al.
Anticancer Research|February 24, 2001
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patientsM Broggini, G Buraggi, A Brenna, et al.
Cancer Research|March 1, 1997
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxelD Debernardis, E G Siré, P De Feudis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Molecular characterisation of a panel of human ovarian carcinoma xenograftsA M Codegoni, M I Nicoletti, G Buraggi, et al.
Bone|October 1, 1995
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosisS Adami, M Passeri, S Ortolani, et al.
Clinical and Experimental Rheumatology|May 1, 1993
Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesionsI Grazioli, M Avossa, A Bogliolo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitoninS Adami, M C Baroni, M Broggini, et al.
British Journal of Cancer|June 3, 2004
Antiangiogenic activity of aplidine, a new agent of marine originG Taraboletti, M Poli, R Dossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
DeltaNp63 expression is associated with poor survival in ovarian cancerS Marchini, M Marabese, E Marrazzo, et al.
Pageof 16